Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials

MLA

Niazi, Muhammad Rafay Khan, et al. “Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials.” Oncology, vol. 35, no. 11, Nov. 2021, p. 708. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.683719940&authtype=sso&custid=ns315887.

APA

Niazi, M. R. K., Jahangir, A., Sahra, S., Sattar, S. B. A., Asti, D., & Bershadskiy, A. (2021, November 1). Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials. Oncology, 35(11), 708.

Chicago

Niazi, Muhammad Rafay Khan, Abdullah Jahangir, Syeda Sahra, Saud Bin Abdul Sattar, Divya Asti, and Alexander Bershadskiy. 2021. “Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials.” Oncology, November 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.683719940&authtype=sso&custid=ns315887.